NCT01968187 - Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 20, 2014

Primary Completion Date

July 16, 2014

Study Completion Date

July 16, 2014

Conditions

Hyperphagia in Prader-Willi Syndrome

Interventions

DRUG

FE 992097

"Each spray pump actuation delivered a 50 μL volume of solution that contained 1.6 mg carbetocin (FE 992097); each dose consisted of 3 spray pump actuations in each nostril that delivered a total of 9.6 mg carbetocin.~Parents were instructed to administer 3 intranasal spray actuations in each nostril 3 times daily before meals for 14 days."

DRUG

Placebo

"Each spray pump actuation delivered a 50 μL volume of sterile sodium chloride solution 0.9%; each dose consisted of 3 spray pump actuations in each nostril.~Parents were instructed to administer 3 intranasal spray actuations in each nostril 3 times daily before meals for 14 days."

Trial Locations (3)

Unknown

Florida University, Gainesville

Winthrop University, Mineola

Vanderbilt University, Nashville